Therefore, we used in vitro cellular assays to verify that the knockdown of GNG12 significantly inhibited the proliferation and migration abilities of glioma cell lines and explored some of the molecular mechanisms of GNG12 in cell signaling pathways. This evidence concerns the gene GNG12 and central nervous system cancer.